Compounds > desacetylnantradol
Page last updated: 2024-09-03

desacetylnantradol and 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate

desacetylnantradol has been researched along with 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate in 1 studies

Compound Research Comparison

Studies
(desacetylnantradol)		Trials
(desacetylnantradol)		Recent Studies (post-2010)
(desacetylnantradol)		Studies
(3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate)		Trials
(3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate)		Recent Studies (post-2010) (3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate)
1800774259

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Houston, DB; Howlett, AC1

Other Studies

1 other study(ies) available for desacetylnantradol and 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate

ArticleYear
Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins.
    Molecular pharmacology, 1993, Volume: 43, Issue:1

    Topics: Animals; Brain Chemistry; Cholic Acids; Cyclohexanols; GTP-Binding Proteins; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Phenanthridines; Rats; Receptors, Cannabinoid; Receptors, Drug; Solubility

1993